‘On 27 November, the government unveiled its overall Industrial Strategy which mapped out a framework to support four key growth sectors, including the life sciences sector.
‘Today’s announcement provides more detail on the life sciences sector deal. This will see significant investment in the sector from around the globe, supported by the government, to ensure that the UK is at the leading edge of breakthrough treatments, innovative medical research and technologies. This, in turn, should lead to more high-skilled jobs being created in Britain.
‘The announcement of government investment from the Industrial Strategy Challenge Fund of up to £210 million to assist in growing the UK’s reputation for pioneering early diagnostics and genomics programmes in collaboration with global pharmaceutical companies such as GSK and Astra Zeneca is also welcomed.
‘Continuing Brexit uncertainty means we have to maximise those areas in which the UK economy currently excels. A challenge will be to make the strategy work for all parts of the country and sector.’